AMGEN INC Income Tax Expense 2007-2026 | AMGN
Beta
What is income tax expense?
Income tax expense is the total amount of income taxes a company owes to federal, state, and foreign governments.
What is AMGEN INC's current income tax expense?
AMGEN INC (AMGN) annual income tax expense for 2025 was $1.26B, a 143.74% increase from 2024. AMGEN INC income tax expense for the quarter ending March 31, 2026 was $265.0M.
What was AMGEN INC's income tax expense in 2024?
AMGEN INC annual income tax expense for 2024 was $519.0M, a 54.39% decline from 2023.
What was AMGEN INC's income tax expense in 2023?
AMGEN INC annual income tax expense for 2023 was $1.14B, a 43.32% increase from 2022.
What is AMGEN INC's 5-year income tax expense CAGR?
AMGEN INC income tax expense grew at a compound annual growth rate (CAGR) of 7.80% from FY2020 to FY2025, going from $869.0M to $1.26B over 5 years.
Income Tax Expense History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+7.8%
FY2020
$869.0M
→
FY2025
$1.26B
07080910111213141516171819202122232425
5 years selected
Income Tax Expense History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $1.26B | +143.7% | 10-K |
| FY2024 | $519.0M | -54.4% | 10-K |
| FY2023 | $1.14B | +43.3% | 10-K |
| FY2022 | $794.0M | -1.7% | 10-K |
| FY2021 | $808.0M | -7.0% | 10-K |
| FY2020 | $869.0M | -32.9% | 10-K |
| FY2019 | $1.30B | +12.6% | 10-K |
| FY2018 | $1.15B | -84.9% | 10-K |
| FY2017 | $7.62B | +428.7% | 10-K |
| FY2016 | $1.44B | +38.7% | 10-K |
| FY2015 | $1.04B | +143.3% | 10-K |
| FY2014 | $427.0M | +132.1% | 10-K |
| FY2013 | $184.0M | -72.3% | 10-K |
| FY2012 | $664.0M | +42.2% | 10-K |
| FY2011 | $467.0M | -32.3% | 10-K |
| FY2010 | $690.0M | +15.2% | 10-K |
| FY2009 | $599.0M | -37.8% | 10-K |
| FY2008 | $963.0M | +34.7% | 10-K |
| FY2007 | $715.0M | - | 10-K |
Company: AMGEN INCTicker: AMGNSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →